대한부인종양학회

최신 논문

총 게시글 : 136

Initial sarcopenia and body composition changes as prognostic factors in cervical cancer patients treated with concurrent chemoradiation: An artificial intelligence-based volumetric study 2024-09-24 VIEW : 0
GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 tria 2024-09-24 VIEW : 10
Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan 2024-09-24 VIEW : 9
Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study 2024-09-24 VIEW : 13
Choosing the right adjuvant therapy for stage III–IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy 2024-09-24 VIEW : 1
Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis 2024-09-24 VIEW : 3
Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006). 2024-09-24 VIEW : 9
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial. 2024-09-24 VIEW : 3
Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer. 2024-09-24 VIEW : 9
Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer. 2024-09-24 VIEW : 1
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial 2024-06-26 VIEW : 36
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations 2024-06-26 VIEW : 13
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies 2024-06-26 VIEW : 5
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses 2024-06-26 VIEW : 4
Vulvar Carcinoma: Standard of Care and Perspectives 2024-06-26 VIEW : 10

1
2
3
4
5
6
7
8
9
10